Cocaine-mediated enhancement of virus replication in macrophages: Implications for human immunodeficiency virus–associated dementia

References

• Anthony J C, Vlahov D, Nelson K E, Cohn S, Astemborski J, Solomon L. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol 1991; 134: 1175–1189
   PubMed Web of Science ®Google Scholar
• Asensio V C, Campbell I L. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci 1999; 22: 504–512
   PubMed Web of Science ®Google Scholar
• Avants S K, Margolin A, McMahon T J, Kosten T R. Association between self-report of cognitive impairment, HIV status, and cocaine use in a sample of cocaine-dependent methadone-maintained patients. Addict Behav 1997; 22: 599–611
   PubMed Web of Science ®Google Scholar
• Bagasra O, Pomerantz R J. Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J Infect Dis 1993; 168: 1157–1164
   PubMed Web of Science ®Google Scholar
• Baldwin G C, Roth M D, Tashkin D P. Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J Neuroimmunol 1998; 83: 133–138
   PubMed Web of Science ®Google Scholar
• Baldwin G C, Tashkin D P, Buckley D M, Park A N, Dubinett S M, Roth M D. Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am J Respir Crit Care Med 1997; 156: 1606–1613
   PubMed Web of Science ®Google Scholar
• Bell J E, Brettle R P, Chiswick A, Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 1998; 12: 2043–2052, (Pt 11)
   Google Scholar
• Borghi P, Fantuzzi L, Varano B, Gessani S, Puddu P, Conti L, Capobianchi M R, Ameglio F, Belardelli F. Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/ macrophages. J Virol 1995; 69: 1284–1287
   PubMedGoogle Scholar
• Buch S, Pinson D, King C L, Raghavan R, Hou Y, Li Z, Adany I, Hicks A, Villinger F, Kumar A, Narayan O. Inhibitory and enhancing effects of IFN-gamma and IL-4 on SHIV(KU) replication in rhesus macaque macrophages: correlation between Th2 cytokines and productive infection in tissue macrophages during late-stage infection. Cytokine 2001; 13: 295–304
   Google Scholar
• Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol 1991; 1: 163–175
   PubMed Web of Science ®Google Scholar
• Chaisson R E, Bacchetti P, Osmond D, Brodie B, Sande M A, Moss A R. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989; 261: 561–565
   PubMed Web of Science ®Google Scholar
• Chiasson M A, Stoneburner R L, Hildebrandt D S, Ewing W E, Telzak E E, Jaffe H W. Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS 1991; 5: 1121–1126
   PubMed Web of Science ®Google Scholar
• Clerici M, Hakim F T, Venzon D J, Blatt S, Hendrix C W, Wynn T A, Shearer G M. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993; 91: 759–765
   PubMed Web of Science ®Google Scholar
• Denis M, Ghadirian E. Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects. AIDS Res Hum Retroviruses 1994; 10: 1619–1627
   PubMedGoogle Scholar
• Dhillon N K, Sui Y, Potula R, Dhillon S, Adany I, Li Z, Villinger F, Pinson D, Narayan O, Buch S. Inhibition of pathogenic SHIV replication in macaques treated with antisense DNA of interleukin-4. Blood 2005; 105: 3094–3099
   Google Scholar
• Doherty M C, Garfein R S, Monterroso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS 2000; 14: 717–726
   PubMed Web of Science ®Google Scholar
• Durvasula R S, Myers H F, Satz P, Miller E N, Morgenstern H, Richardson M A, Evans G, Forney D. HIV-1, cocaine, and neuropsychological performance in African American men. J Int Neuropsychol Soc 2000; 6: 322–335
   PubMed Web of Science ®Google Scholar
• Eisenstein T K, Hilburger M E. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J Neuroimmunol 1998; 83: 36–44
   PubMed Web of Science ®Google Scholar
• Emiliani S, Van Lint C, Fischle W, Paras P, Jr, Ott M, Brady J, Verdin E. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc Natl Acad Sci U S A 1996; 93: 6377–6381
   PubMed Web of Science ®Google Scholar
• Ferreira I D, Rosario V E, Cravo P V. Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum. Malar J 2006; 5: 1
   Web of Science ®Google Scholar
• Fiala M, Gan X H, Zhang L, House S D, Newton T, Graves M C, Shapshak P, Stins M, Kim K S, Witte M, Chang S L. Cocaine enhances monocyte migration across the blood-brain barrier. Cocaine's connection to AIDS dementia and vasculitis?. Adv Exp Med Biol 1998; 437: 199–205
   PubMed Web of Science ®Google Scholar
• Finnegan A, Roebuck K A, Nakai B E, Gu D S, Rabbi M F, Song S, Landay A L. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J Immunol 1996; 156: 841–851
   PubMedGoogle Scholar
• Friedman H, Newton C, Klein T W. Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 2003; 16: 209–219
   PubMed Web of Science ®Google Scholar
• Gardner B, Zhu L X, Roth M D, Tashkin D P, Dubinett S M, Sharma S. Cocaine modulates cytokine and enhances tumor growth through sigma receptors. J Neuroimmunol 2004; 147: 95–98
   PubMed Web of Science ®Google Scholar
• Glass J D, Fedor H, Wesselingh S L, McArthur J C. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995; 38: 755–762
   PubMed Web of Science ®Google Scholar
• Glass J D, Wesselingh S L, Selnes O A, McArthur J C. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 1993; 43: 2230–2237
   PubMedGoogle Scholar
• Goodkin K, Shapshak P, Metsch L R, McCoy C B, Crandall K A, Kumar M, Fujimura R K, McCoy V, Zhang B T, Reyblat S, Xin K Q, Kumar A M. Cocaine abuse and HIV-1 infection: epidemiology and neuropathogenesis. J Neuroimmunol 1998; 83: 88–101
   PubMed Web of Science ®Google Scholar
• Gray F, Adle-Biassette H, Brion F, Ereau T, le M I, Levy V, Corcket G. Neuronal apoptosis in human immunodeficiency virus infection. J NeuroVirol 2000; 6: S38–S43, (Suppl 1)
   Google Scholar
• Hauser K F, El Hage N, Stiene-Martin A, Maragos W F, Nath A, Persidsky Y, Volsky D J, Knapp P E. HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse. J Neurochem 2007; 100: 567–586
   PubMed Web of Science ®Google Scholar
• Hicks A, Potula R, Sui Y J, Villinger F, Pinson D, Adany I, Li Z, Long C, Cheney P, Marcario J, Novembre F, Mueller N, Kumar A, Major E, Narayan O, Buch S. Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages. Am J Pathol 2002; 161: 813–822
   Web of Science ®Google Scholar
• Kaul M, Garden G A, Lipton S A. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410: 988–994
   PubMed Web of Science ®Google Scholar
• Klein T W, Matsui K, Newton C A, Young J, Widen R E, Friedman H. Cocaine suppresses proliferation of phytohemagglutinin-activated human peripheral blood T-cells. Int J Immunopharmacol 1993; 15: 77–86
   PubMed Web of Science ®Google Scholar
• Larrat E P, Zierler S. Entangled epidemics: cocaine use and HIV disease. J Psychoactive Drugs 1993; 25: 207–221
   PubMed Web of Science ®Google Scholar
• Mao J T, Huang M, Wang J, Sharma S, Tashkin D P, Dubinett S M. Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-gamma production. Cell Immunol 1996; 172: 217–223
   Web of Science ®Google Scholar
• Nair M PN, Mahajan S, Hou J, Sweet A M, Schwartz S A. The stress hormone, cortisol, synergizes with HIV-1 gp-120 to induce apoptosis of normal human peripheral blood mononuclear cells. Cell Mol Biol 2000; 46: 1227–1238
   Web of Science ®Google Scholar
• Nath A. Pathobiology of human immunodeficiency virus dementia. Semin Neurol 1999; 19: 113–127
   Google Scholar
• Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, Bell J, Hauser K F, Mattson M. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol 2000; 14: 222–227
   PubMed Web of Science ®Google Scholar
• Nath A, Hauser K F, Wojna V, Booze R M, Maragos W, Prendergast M, Cass W, Turchan J T. Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 2002; 31: S62–S69, (Suppl 2)
   PubMed Web of Science ®Google Scholar
• Nath A, Maragos W F, Avison M J, Schmitt F A, Berger J R. Acceleration of HIV dementia with methamphetamine and cocaine. J NeuroVirol 2001; 7: 66–71
   PubMed Web of Science ®Google Scholar
• Osborn L, Kunkel S, Nabel G J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A 1989; 86: 2336–2340
   PubMed Web of Science ®Google Scholar
• Pantaleo G, Graziosi C, Fauci A S. The immunopathogenesis of human-immunodeficiency-virus infection. N Engl J Med 1993; 328: 327–335
   PubMed Web of Science ®Google Scholar
• Peterson P K, Gekker G, Chao C C, Schut R, Molitor T W, Balfour H H. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. J Immunol 1991; 146: 81–84
   PubMed Web of Science ®Google Scholar
• Peterson P K, Gekker G, Chao C C, Schut R, Verhoef J, Edelman C K, Erice A, Balfour H H, Jr. Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures. J Immunol 1992; 149: 676–680
   Google Scholar
• Peterson P K, Gekker G, Schut R, Hu S, Balfour H H, Jr, Chao C C. Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection. Adv Exp Med Biol 1993; 335: 181–188
   Google Scholar
• Peterson P K, Sharp B M, Gekker G, Portoghese P S, Sannerud K, Balfour H H. Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS 1990; 4: 869–873
   PubMed Web of Science ®Google Scholar
• Reyes M G, Faraldi F, Senseng C S, Flowers C, Fariello R. Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 1991; 82: 39–44
   PubMed Web of Science ®Google Scholar
• Roth M D, Tashkin D P, Choi R, Jamieson B D, Zack J A, Baldwin G C. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J Infect Dis 2002; 185: 701–705
   PubMedGoogle Scholar
• Selwyn P A, Alcabes P, Hartel D, Buono D, Schoenbaum E E, Klein R S, Davenny K, Friedland G H. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992; 327: 1697–1703
   PubMed Web of Science ®Google Scholar
• Shapshak P, Crandall K A, Xin K Q, Goodkin K, Fujimura R K, Bradley W, McCoy C B, Nagano I, Yoshioka M, Petito C, Sun N C, Srivastava A K, Weatherby N, Stewart R, Delgado S, Matthews A, Douyon R, Okuda K, Yang J, Zhangl B T, Cao X R, Shatkovsky S, Fernandez J B, Shah S M, Perper J. HIV-1 neuropathogenesis and abused drugs: current reviews, problems, and solutions. Adv Exp Med Biol 1996; 402: 171–186
   Google Scholar
• Smith M S, Niu Y, Li Z, Adany I, Pinson D M, Liu Z Q, Berry T, Sheffer D, Jia F, Narayan O. Systemic infection and limited replication of SHIV vaccine virus in brains of macaques inoculated intracerebrally with infectious viral DNA. Virology 2002; 301: 130–135
   PubMed Web of Science ®Google Scholar
• Srikanth P, Castillo R C, Sridharan G, John T J, Zachariah A, Mathai D, Schwartz D H. Increase in plasma IL-10 levels and rapid loss of CD4+ T cells among HIV-infected individuals in south India. Int J STD AIDS 2000; 11: 49–51
   PubMed Web of Science ®Google Scholar
• Stanulis E D, Jordan S D, Rosecrans J A, Holsapple M P. Disruption of Th1/Th2 cytokine balance by cocaine is mediated by corticosterone. Immunopharmacology 1997; 37: 25–33
   PubMedGoogle Scholar
• Steele A D, Henderson E E, Rogers T J. Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology 2003; 309: 99–107
   PubMed Web of Science ®Google Scholar
• Stylianou E, Aukrust P, Kvale D, Muller F, Froland S S. IL-10 in HIV infection: increasing serum IL-10 levels with disease progression—down-regulatory effect of potent anti-retroviral therapy. Clin Exp Immunol 1999; 116: 115–120
   PubMed Web of Science ®Google Scholar
• Tyor W R, Middaugh L D. Do alcohol and cocaine abuse alter the course of HIV-associated dementia complex?. J Leukoc Biol 1999; 65: 475–481
   PubMed Web of Science ®Google Scholar
• Tyor W R, Wesselingh S L, Griffin J W, McArthur J C, Griffin D E. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 379–388
   PubMedGoogle Scholar
• Weissman D, Poli G, Fauci A S. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 442–449
   Google Scholar
• Wiley C A, Achim C L, Christopherson C, Kidane Y, Kwok S, Masliah E, Mellors J, Radhakrishnan L, Wang G, Soontornniyomkij V. HIV mediates a productive infection of the brain. AIDS 1999; 13: 2055–2059
   PubMed Web of Science ®Google Scholar